Table 2 Pre-operative imaging and histopathology data
Total of patients included: n = 60 | |
|---|---|
Echocardiography | |
Aortic valve area, cm2 | 0.67 ± 0.19 |
Maximum aortic gradient, mmHg | 99.89 ± 30.58 |
Mean aortic gradient, mmHg | 63.1 ± 20.2 |
Stroke volume index, mL/m2 | 43.97 ± 9.31 |
LV indexed mass, g/m2 | 141.73 (67.27–360.83) |
Maximum septal thickness, mm | 16.0 ± 2.8 |
LVEF, % | 57.01 ± 8.32 |
Global longitudinal strain, % | –14.57 ± 3.77 |
PLAX cIBS, dB | –17.45 (–31.2–10.95) |
AP3C cIBS, dB | –9.17 ± 9.45 |
AP3C, strain derived IBS, dB | 113.99 ± 22.59 |
Cardiac Magnetic Resonance | |
LV indexed mass, g/m2 | 76.2 ± 23.3 |
LVEDV, mL | 148.9 ± 37.6 |
Geometric remodeling, g/mL | 0.93 ± 0.22 |
LVEF, % | 59.6 ± 9.0 |
Delayed enhancement, g | 3.03 (0–23.8) |
Delayed enhancement, % of mass | 2.50 (0.0–21.0) |
Global native T1, ms | 1049.5 (947.0–1179.0) |
Basal anteroseptal native T1, ms | 1071.0 (965.0–10130.0) |
Global ECV, % | 24.0 (15.0–54.0) |
Basal anteroseptal ECV, % | 22.0 (13.1–44.2) |
Histopathology at EMB | |
Fibrosis, % (CVF) | 9.7 (6.15–16.7) |